Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrronium bromide for hypersalivation in Parkinson's disease
NL-OMON20228Active, not recruiting
- Sponsor
- M.E.L. Arbouw
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of glycopyrronium in hypersalivation (2 arms), sponsored by M.E.L. Arbouw. Primary endpoint: Responder rate based on hypersalivation score. Started Feb 2007; status: active, not recruiting.
02
Drugs
glycopyrronium
03
Conditions
hypersalivation
Beyond the preview
Go deeper on NL-OMON20228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20228.